Skip to content
    • About the Library
    • Rules and Regulations
    • Library Services
    • Library Hours
  • Library News
    • Digital Repository
    • Google Scholar
    • ResearchGate
    • AJoGPL
    • KURJ
    • AJLS
    • MyLOFT
    • Lexis Plus UK
    • Britannica Academic
    • Research Support Tools
    • Quick Resource Links
  • Login
Advanced
  • Universal driving restrictions...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

Saved in:
Bibliographic Details
Main Authors: Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer, Djordje Atanackovic, Shebli Atrash, Veronika Bachanova, Amer M. Beitinjaneh, Evguenia Bhurtel, Omar Castaneda Puglianini, Saurabh Chhabra, Kara I. Cicero, James A. Davis, Binod Dhakal, Danai Dima, Christopher J. Ferreri, Peter A. Forsberg, Ciara L. Freeman, Megan M. Herr, Tania Jain, Murali Janakiram, Jack Khouri, Mehmet H. Kocoglu, Anupama Kumar, Yuxin Liu, Frederick Locke, Joseph P. McGuirk, Lekha Mikkilineni, Omar Nadeem, Ricardo D. Parrondo, Oren Pasvolsky, Lauren C. Peres, Sneha Purvey, Shahzad Raza, Ran Reshef, Shambavi Richard, Adriana C. Rossi, Douglas W. Sborov, Leyla Shune, Charlotte B. Wagner, Saurabh S. Zanwar, Surbhi Sidana, Krina K. Patel, Doris K. Hansen, Shaji K. Kumar, Yi Lin, Thomas G. Martin, Peter M. Voorhees, Larry D. Anderson, Jr, Andrew J. Cowan, Gurbakhash Kaur
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952925001715
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2473952925001715

Similar Items

  • Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
    by: Oren Pasvolsky, et al.
    Published: (2025-05-01)
  • Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
    by: Danai Dima, et al.
    Published: (2025-06-01)
  • Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment
    by: Danai Dima, et al.
    Published: (2025-07-01)
  • Soil Carbon Remote Sensing: A Meta-Analysis and Systematic Review of Published Results from 1969–2022
    by: Savannah L. McGuirk, et al.
    Published: (2025-05-01)
  • BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement
    by: Mahmoud R. Gaballa, et al.
    Published: (2025-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs